Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Vercruysse

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Nature Communications|January 3, 2024
Multiplexed multicolor antiviral assay amenable for high-throughput researchLi-Hsin Li, Winston Chiu, Yun-An Huang, et al.
Ebiomedicine|August 30, 2022
Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster modelsJi Ma, Michael Bright Yakass, Sander Jansen, et al.
Viruses|June 24, 2022
High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in BelgiumBas Calcoen, Nico Callewaert, Aline Vandenbulcke, et al.
Nature Communications|November 5, 2022
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamstersSapna Sharma, Thomas Vercruysse, Lorena Sanchez-Felipe, et al.
The EMBO Journal|March 11, 2021
HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutationsRaheem Fazal, Steven Boeynaems, Ann Swijsen, et al.
Nature Communications|December 13, 2025
Immunological and transcriptomic profile of chimeric live-attenuated Zika vaccine linked to protection in non-human primatesJi Ma, Bert Malengier-Devlies, Babs E Verstrepen, et al.
Microbiology Spectrum|June 7, 2022
A High-Throughput Yellow Fever Neutralization AssayMadina Rasulova, Thomas Vercruysse, Jasmine Paulissen, et al.
Iscience|July 11, 2022
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster modelMaya Imbrechts, Wim Maes, Louanne Ampofo, et al.
Cell|July 8, 2023
TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entryJim Baggen, Maarten Jacquemyn, Leentje Persoons, et al.
Molecular Cell|March 18, 2017
Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule DynamicsSteven Boeynaems, Elke Bogaert, Denes Kovacs, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Nature Communications|January 3, 2024
Multiplexed multicolor antiviral assay amenable for high-throughput researchLi-Hsin Li, Winston Chiu, Yun-An Huang, et al.
Ebiomedicine|August 30, 2022
Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster modelsJi Ma, Michael Bright Yakass, Sander Jansen, et al.
Viruses|June 24, 2022
High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in BelgiumBas Calcoen, Nico Callewaert, Aline Vandenbulcke, et al.
Nature Communications|November 5, 2022
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamstersSapna Sharma, Thomas Vercruysse, Lorena Sanchez-Felipe, et al.
The EMBO Journal|March 11, 2021
HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutationsRaheem Fazal, Steven Boeynaems, Ann Swijsen, et al.
Nature Communications|December 13, 2025
Immunological and transcriptomic profile of chimeric live-attenuated Zika vaccine linked to protection in non-human primatesJi Ma, Bert Malengier-Devlies, Babs E Verstrepen, et al.
Microbiology Spectrum|June 7, 2022
A High-Throughput Yellow Fever Neutralization AssayMadina Rasulova, Thomas Vercruysse, Jasmine Paulissen, et al.
Iscience|July 11, 2022
Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster modelMaya Imbrechts, Wim Maes, Louanne Ampofo, et al.
Cell|July 8, 2023
TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entryJim Baggen, Maarten Jacquemyn, Leentje Persoons, et al.
Molecular Cell|March 18, 2017
Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule DynamicsSteven Boeynaems, Elke Bogaert, Denes Kovacs, et al.
Pageof 4